NCT03643081View on ClinicalTrials.gov

"Evaluation of the Interest of the Medical Device Called Fluobeam in the Localization, Visualization of the Parathyroid Glands for Patients With Mild Primary Hyperparathyroidism"

NACompletedINTERVENTIONAL

Enrollment

132

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

January 8, 2024

Study Completion Date

January 8, 2024

Conditions

Mild Primary Hyperparathyroidism

Interventions

DEVICE

"Use of the camera Fluobeam"

"Use of the camera Fluobeam to localize, visualize the parathyroid glands during a parathyroidectomy."

Trial Locations (1)

44093

CHU de Nantes, Nantes

All Listed Sponsors

lead

Nantes University Hospital

OTHER

NCT03643081 - "Evaluation of the Interest of the Medical Device Called Fluobeam in the Localization, Visualization of the Parathyroid Glands for Patients With Mild Primary Hyperparathyroidism" | Biotech Hunter | Biotech Hunter